Scan to download
Coin: HqaYjLkyq8SKepcQmXzH45g88rL8QnR31ZDNW7RKpump
replies: 3
Retatrutide (RETA): Retatrutide is an investigational, once-weekly "triple G" (GIP, GLP-1, and Glucagon) receptor agonist developed by Eli Lilly for obesity and type 2 diabetes. Clinical trials show it provides superior weight loss (up to ~24–28.7% over 68 weeks) compared to current drugs, with Phase 3 trials concluding in early 2026.
Insults, Unwanted Sexual Content & Graphic Objectification, Unwanted NSFW & Graphic Content, Violent Event Denial, Targeted Harassment and Inciting Harassment
Child sexual exploitation, grooming, physical child abuse, underage user
Encouraging, promoting, providing instructions or sharing strategies for self-harm.
Graphic Content, Gratuitous Gore, Adult Nudity & Sexual Behavior, Violent Sexual Conduct, Bestiality & Necrophilia, Media depicting a deceased individual.
Please explain why should be removed.
